(Q34578381)

English

Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer.

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

11916237

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916237%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 December 2019

review article

1 reference

stated in

Europe PubMed Central

title

Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

11916237

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916237%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 December 2019

author name string

Kurokawa H

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

11916237

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916237%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 December 2019

Arteaga CL

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

11916237

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916237%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 December 2019

language of work or name

English

0 references

publication date

1 December 2001

1 reference

stated in

Europe PubMed Central

PubMed ID

11916237

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916237%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 December 2019

published in

Clinical Cancer Research

1 reference

stated in

Europe PubMed Central

PubMed ID

11916237

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916237%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 December 2019

volume

7

1 reference

stated in

Europe PubMed Central

PubMed ID

11916237

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916237%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 December 2019

page(s)

4436s-4442s; discussion 4411s-4412s

1 reference

stated in

Europe PubMed Central

PubMed ID

11916237

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916237%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 December 2019

issue

12 Suppl

1 reference

stated in

Europe PubMed Central

PubMed ID

11916237

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916237%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 December 2019

Identifiers

PubMed ID

11916237

1 reference

stated in

Europe PubMed Central

PubMed ID

11916237

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11916237%20AND%20SRC:MED&resulttype=core&format=json

(Q34578381)

Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)